Risk of acute myocardial infarction in patients with gastroesophageal reflux disease: A nationwide population-based study.
Wei-Yi LeiJen-Hung WangShu-Hui WenChih-Hsun YiJui-Sheng HungTso-Tsai LiuWilliam C OrrChien-Lin ChenPublished in: PloS one (2017)
This large population-based study demonstrates an association between GERD and future development of AMI, however, PPIs use only achieved marginal significance in reducing the occurrence of AMI in GERD patients. Further prospective studies are needed to evaluate whether anti-reflux medication may reduce the occurrence of acute ischemic event in GERD patients.
Keyphrases
- acute myocardial infarction
- end stage renal disease
- gastroesophageal reflux disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- heart failure
- liver failure
- emergency department
- patient reported outcomes
- percutaneous coronary intervention
- coronary artery disease
- brain injury
- subarachnoid hemorrhage
- patient reported
- drug induced